MSB 8.42% $1.03 mesoblast limited

Ann: FDA Grants Rare Pediatric Disease Designation for Revascor, page-255

  1. 7,841 Posts.
    lightbulb Created with Sketch. 1345
    Yeah recruitment might be more efficient, but they're recruiting many more people.

    The last one took what, 8 years from approval?

    So it's definitely at least a couple years for the next - that's a fair assumption, no?

    Am I wrong?
    Last edited by DocMcstuffins: 24/01/24
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.